Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Acidosis, Lactic

ribavirin has been researched along with Acidosis, Lactic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (85.71)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farnik, H; Herrmann, E; Lange, CM; Luhne, S; Sarrazin, C; Vermehren, J; Welker, MW; Welzel, T; Zeuzem, S1
Cano, Y; Guyader, D; Poinsignon, Y; Saout, L1
Montes Ramírez, ML; Rodríguez Zapata, M1
Butt, AA1
Gerber, JG; Glesby, MJ1

Reviews

1 review(s) available for ribavirin and Acidosis, Lactic

ArticleYear
Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity.
    The AIDS reader, 2003, Volume: 13, Issue:7

    Topics: Acidosis, Lactic; Anti-HIV Agents; Antiviral Agents; Didanosine; DNA, Mitochondrial; Drug Synergism; Hepatitis C; HIV Infections; Humans; Metabolic Clearance Rate; Pancreatitis; Ribavirin

2003

Other Studies

6 other study(ies) available for ribavirin and Acidosis, Lactic

ArticleYear
Lactic acidosis in patients with hepatitis C virus cirrhosis and combined ribavirin/sofosbuvir treatment.
    Journal of hepatology, 2016, Volume: 64, Issue:4

    Topics: Acidosis, Lactic; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; RNA, Viral; Sofosbuvir

2016
Fatal lactic acidosis in a HIV-positive patient treated with interferon and ribavirin for chronic hepatitis C.
    Journal of hepatology, 2002, Volume: 37, Issue:2

    Topics: Acidosis, Lactic; Adult; Antiviral Agents; Fatal Outcome; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Ribavirin

2002
[Report of three cases of hyperlactacidemiae/lactic acidosis after treatment of hepatitis C with pegylated interferon and ribavirin in HIV coinfected patients].
    Revista clinica espanola, 2002, Volume: 202, Issue:10

    Topics: Acidosis, Lactic; Adult; Antiviral Agents; Female; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2002
Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy.
    The AIDS reader, 2003, Volume: 13, Issue:7

    Topics: Acidosis, Lactic; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Synergism; Drug Therapy, Combination; Fatal Outcome; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pancreatitis; Recombinant Proteins; Ribavirin; Risk Factors; Viral Load

2003
Hepatitis C and didanosine: risk of lactic acidosis.
    Prescrire international, 2005, Volume: 14, Issue:80

    Topics: Acidosis, Lactic; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Comorbidity; Contraindications; Didanosine; Drug Interactions; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin

2005
Treatment of hepatitis C in HIV-infected patients: regularly reassess the benefits and risks.
    Prescrire international, 2005, Volume: 14, Issue:80

    Topics: Acidosis, Lactic; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clinical Trials as Topic; Cost-Benefit Analysis; Disease Progression; Drug Interactions; Drug Therapy, Combination; Fibrosis; Genotype; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin

2005